Selected article for: "cell membrane and host cell membrane"

Author: Lin Li; Ting Sun; Yufei He; Wendong Li; Yubo Fan; Jing Zhang
Title: Epitope-based peptide vaccine design and target site characterization against novel coronavirus disease caused by SARS-CoV-2
  • Document date: 2020_2_27
  • ID: e9vq3fe3_3
    Snippet: Structural proteins are important targets for vaccine and anti-viral drug development due to their indispensable function to fuse and enter into the host cell [8] . SARS-CoV-2 utilizes glycosylated spike (S) protein to gain entry into host cells. The S protein is a trimeric class I fusion protein and exists in a metastable prefusion conformation that undergoes a dramatic structural rearrangement to fuse the viral membrane with the host-cell membr.....
    Document: Structural proteins are important targets for vaccine and anti-viral drug development due to their indispensable function to fuse and enter into the host cell [8] . SARS-CoV-2 utilizes glycosylated spike (S) protein to gain entry into host cells. The S protein is a trimeric class I fusion protein and exists in a metastable prefusion conformation that undergoes a dramatic structural rearrangement to fuse the viral membrane with the host-cell membrane [1, 9, 10] . The S protein includes the receptor binding S1-subunit and the membrane fusion S2-subunit. The S1 subunit receptor-binding domain (RDB) is specifically recognized by the host receptor. When the S1 subunit binds to a host-cell receptor, the prefusion trimer is destabilized, resulting in the shedding of S1 subunit, and the state transition of S2 subunit to a stable postfusion conformation [11] . The critical function of the S protein can be a breakthrough in vaccine design and development.

    Search related documents:
    Co phrase search for related documents
    • anti viral drug development and drug development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16
    • anti viral drug development and entry gain: 1
    • anti viral drug development and host cell: 1
    • anti viral drug development and membrane fusion: 1
    • anti viral drug development vaccine and development vaccine design: 1, 2
    • anti viral drug development vaccine and drug development: 1, 2, 3
    • anti viral drug development vaccine and entry gain: 1
    • anti viral drug development vaccine and host cell: 1
    • anti viral drug development vaccine and membrane fusion: 1
    • critical function and development vaccine design: 1
    • critical function and drug development: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • critical function and host cell: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • critical function and host cell membrane: 1, 2
    • critical function and host cell receptor: 1, 2
    • critical function and host receptor: 1, 2, 3, 4
    • critical function and membrane fusion: 1, 2, 3, 4, 5, 6, 7
    • development vaccine design and host receptor: 1, 2, 3, 4, 5
    • development vaccine design and important target: 1, 2, 3
    • development vaccine design and membrane fusion: 1, 2, 3